We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.

Show Preview: INTERPHEX 2011 Unveils Latest Roster Of Special Events, Expert Speakers, Education, Exhibits

03/03/2011

(NORWALK, Conn., March 03, 2011) – “Innovation, Intelligence and Passion” are the official watchwords for INTERPHEX 2011, and they are words its organizers have taken to heart in developing this year’s event, which will be held at New York’s Jacob K. Javits Convention Center on March 29 – 31, 2011.  

More than 650 suppliers (including more than 100 new exhibitors) and 1,000 product lines will fill the show floor’s four exhibit Zones: Facilities, Sourcing & Services, Automation: Systems & Controls and Manufacturing & Packaging. Adding to the activity will be more than thirty technical sessions, roundtables, live in-depth interviews, a new meeting service and a series of special events.

Special Events: From FOYA to Technology Tours -- and More

This year marks ISPE’s 14th year as the major sponsor of INTERPHEX, and both organizations will join with Pharmaceutical Processing magazine to showcase category winners in the seventh annual Facility of the Year Award (FOYA) program, in a special winners’ center in the Facilities Zone:

    • Process Innovation: F. Hoffman – La Roche Ltd.: “MyDose” Clinical Supply facility in Kaiseraugst, Switzerland
    • Facility Integration: Merck & Co., Inc.: Global Clinical Supplies Manufacturing, Packaging and Warehouse Expansion, Summit, New Jersey, USA
    • Project Execution: MedImmune, LLC: Frederick Manufacturing Center (FMC) Expansion facility in Frederick, Maryland, USA
    • Equipment Innovation: Novartis Vaccines and Diagnostics GmbH: “MARS Project” (Marburg Site) facility in Marburg, Germany
    • Operational Excellence: Pfizer Health AB: Project Pegasus – Bio 7 Manufacturing facility in Strängnäs, Sweden
    • Sustainability: Pfizer Manufacturing Deutschland GmbH: SPRING & E-MAP (Strategic Plant Restructuring & Energy Master Plan) project in Freiburg, Germany
    • Honorable Mention: Shire HGT: Project Atlas, Building 400 facility in Lexington, Massachusetts, USA.

Adding to the FOYA event anticipation is the realization that this is the only joint appearance the winners will make apart from the ISPE Annual Meeting in November 2011, when one category winner will be named Overall Winner.

Integrated Project Services (IPS), which provides technical consulting, engineering, construction and commissioning and qualification services, will also host two technology tours focusing on single-use (SU) bioprocessing and advanced aseptic processing technologies. The tours will be held on March 30, with participating exhibitor subject matter experts outlining available technologies and unique equipment configurations. There will also be an aseptic and SU reception.

Returning to headline the Main Stage will be The Signature Series, a two-day lineup of programs and interviews with global experts, led by Michelle Hoffman, Editorial Director of Pharmaceutical Technology magazine:

  • Challenges for Continuous Processing: Moheb Nasr, Director, Office of new Drug Quality Assessment, CDER, FDA; Alex Cheung, Director/Team Leader of the Technology, Science and Operations Group, Pfizer Global Supply Division, Pfizer Inc.; Fernando Muzzio, Professor Chemical Engineering, Rutgers University and President, Mixing Consultants, Inc.
  • The Future for a Fully Integrated Platform: James Evans, Associate Director Novartis-MIT Center for Continuous Manufacturing
  • Automating Stem-Cell Manufacturing: Bob Speziale, Vice President Business Development, Invetech
  • China: The New Pharma Frontier: Xiong Yu, Vice President, China Institute for the Pharmaceutical Industry (CIPI); Feng Li, Senior Vice President, Advanced Pharmaceuticals. Presented in conjunction with Advanced Pharmaceuticals.
  • Jim Miller on Outsourcing: Jim Miller, President and CEO, PharmSource and Outsourcing Columnist, Pharmaceutical Technology and a respected outsourcing consultant, returns to INTERPHEX for his annual review of important trends for contract providers. This will be held in Room #1E07.
  • Outsourcing Discussion: Mark Scheftel, Executive Director, Direct Materials Procurement, Merck Global Procurement; Peter T. Bigelow, President, North American Operations, Patheon. Moderated by Jim Miller. On the Main Stage.


And adding to the knowledge base will be luncheon roundtables presented by BioProcess International, including the panel discussions “Cell Therapies: Commercializing a New Class of Biopharmaceuticals” with Dominic Clarke, Charter Medical; Robert Perry, Athersys, Robert Preti, Progenitor Cell Therapy; and Jon Rowley, Lonza; and “Vaccines – Enabling Technologies for Biotechnology’s Brave New World” with Vikas Gupta, Merck; Rick Hancock, Althea Technologies; Peter Latham, BioPharm Services US; and James Wilkins, Sensorin.

For some INTERPHEX goers a special event may be the individual meeting that makes a difference, arranged through this year’s new INTERPHEXConnects One2One Meetings, sponsored by Contract Pharma. The new service will bring attendees with sourcing needs together with contract manufacturers and other service providers exhibiting in the Sourcing & Services Zone, where the staffed meeting center will be located. Eligible attendees will be able to book up to five meetings in advance, in six private meeting rooms. Meetings arranged on-site will also be available.

Rounding out the special events roster will be the Opening Night Reception, open to all attendees and exhibitors.

The Latest Knowledge: Educational Programming

Event organizers and the 2011 INTERPHEX Advisory Board have developed a two-day program of comprehensive technical education with more than thirty sessions that address contemporary pharmaceutical issues and provide immediately usable knowledge. A sampling of the sessions includes:

  • PAT: a Disjointed Product Approach or an Integrated Solution to Deliver Real Manufacturing Benefits? Ali Afnan, Step Change Pharma, Inc.; Martin Gadsby, Optimal Industrial Automation Ltd.; Martin Warman, Vertex Pharmaceuticals.
  • Single-use Technology and its Impact on Aseptic Fill/Finish Facilities. Jason Collins, Integrated Project Services; Rob Roy, Integrated Project Services.
  • An Innovative Approach to Improving 'First Pass Success' of Production Scale Column Packing.Frank Gaibor, Maxiom Group.
  • Aseptic Processing Facility Design and Machine Integration: A Unique Case Study. Sterling Kline.  Integrated Project Services (IPS); Pat Poisson, United Therapeutics.
  • Applications of Multivariate Data Analyses and Real-time Multivariate Process Monitoring in Biopharmaceutical Manufacturing. Tony Wang, Amgen.
  • Cutting Costs by Being Energy Efficient: Case Studies on Meeting the ENERGY STAR Challenge for Industry. Thomas Pagliuco, Merck; Walt Tunnessen, ENERGY STAR, US EPA
  • Pandemic Preparedness and the Manufacturing of an Emergency Vaccine: What Role can Single Use Systems Play? Manon Cox, Protein Sciences Corp.;Daniella Kranjac,GE Healthcare Lifesciences; Kim Nelson, CRB Consulting Engineers.
  • Continuous Manufacturing, a Regulatory Perspective. Francis Godwin, Federal Drug Administration.
  • Rapid Deployment of a Single-Use Biotech Facility. Bruce Kane, Honeywell; Mark Albano, Honeywell Process Solutions; Lloyd Vallance,  Shire HGT.
  • Risk or Reward: Exploring the Challenges of Manufacturing and Distribution Operations in Emerging Markets. Carla Reed, President, New Creed
  • Microbial Controls in Biopharmaceutical Manufacturing. E.J. Brandreth, Vice President, Althea; Jaspreet Sidhu, PhD, Vice President, Business Development and Pharmaceutical Microbiology, Molecular Epidemiology, Inc. (MEI); Steve Weitzel, Vice President Technical Operations, CANI.

Attendees also have the opportunity to submit questions to the Conference Program speakers in advance, at www.INTERPHEX.com.

More Details and Connections

Details on registration, conference packages, group and ISPE Member discounts can be found at www.interphex.com and the latest news and offerings at INTERPHEX 2011 can be found at Facebook, Twitter and LinkedIn.

Additional industry expert input can be found at the new INTERPHEXConnects blog, which provides timely commentary relevant to biopharmaceutical and pharmaceutical manufacturing, with reader conversation and feedback.

Co-locating with INTERPHEX 2011 at the Javits Convention Center will be BuildingsNewYork/ GreenBuildingsNewYork, which will enable facility managers and other interested buyers from pharmaceutical plants to visit that event at no additional cost. BuildingsNewYork/GreenBuildingsNewYork attracts more than 5,000 architects, engineers, contractors, developers, building owners and property managers and is considered the largest annual gathering for the metropolitan New York-regional building community.

About INTERPHEX

INTERPHEX USA is the world’s most trusted source for leading-edge technology, education, and sourcing of the products and services that drive scientific innovation for Life Sciences manufacturing. INTERPHEX is produced by Reed Exhibitions, delivering influential leaders in life sciences through unique combinations of conference, exhibition, workshops, partnering opportunities, and networking events.

Reed Exhibitions manages more than 450 trade events annually worldwide and is a member of the Reed Elsevier Group plc, a world-leading provider of information-driven services and solutions. For information, visit www.INTERPHEX.com and follow INTERPHEX on Facebook, and Twitter (@INTERPHEX).

Join Our Mailing List
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement